Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Asia Sejahtera Mina Tbk (AGAR) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Asia Sejahtera Mina Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Asia Sejahtera Mina Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asia Sejahtera Mina Tbk trades at Rp208 (market cap 206B, 38.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Asia Sejahtera Mina Tbk is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 38.2K). Which is the better fit depends on your goals.

AGAROBAT
Market Cap
206B160.57B
Volume
38.2K2.51M
Lot
38225.09K
Turnover
8.04M636.74M
Average Price
210.49253.78
Value
8.04M636.74M
Indicative Equilibrium Price
208242
Indicative Equilibrium Volume
10146

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AGAR
View details
OBAT
View details

About Asia Sejahtera Mina Tbk

PT Asia Sejahtera Mina Tbk (the Company) was established based on Notarial Deed No. 12 dated August 27, 2008 of Amelia Kasih, S.H., MKn. The parent company of the Company is PT Sinar Terang Asia Raya and the main parent entity is PT Indo Kreasi Pratama, both of which were established in Indonesia.

Read more on AGAR

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT